How many institutions held IOBTQ - IO Biotech, Inc. - Common Stock, par value $0.001 per share in Q2 2023?

15 institutional investors reported IOBTQ - IO Biotech, Inc. - Common Stock, par value $0.001 per share for Q2 2023. Use the holders table for investor-level position and value details.

IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBTQ)

Q: What does CUSIP 449778109 represent in this 13F holders report?

CUSIP 449778109 is the security identifier for IOBTQ - IO Biotech, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 449778109

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 12,246,779
Total 13F value: $23,953,554
Share change: -1,670,774
SEC-reported price per share: $1.96
Number of holders: 15
Value change: -$3,111,706
Number of buys: 6
Number of sells: 6
Shares outstanding: 79,751,533

Security key

449778109

Report period

Q2 2023

Institutions

Top holders

IOBTQ full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 IO Biotech, Inc. SEC filings IO Biotech, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 449778109

Newer quarter: Q3 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of IOBTQ - IO Biotech, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

HBM Healthcare Investment...

Disclosed value leader

Novo Holdings A/S

Comparable rows

0/15

Latest evidence

31 Mar 2023

3/4/5 13F Highest disclosed value: $6,146,123 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Novo Holdings A/S has the largest disclosed position value at $6.15M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Novo Holdings A/S's linked filing trail.

Disclosed position value Top 5

HBM Healthcare Investments (Cayma... $2.78M

Novo Holdings A/S $6.15M

Vivo Capital, LLC $5.65M

Avoro Capital Advisors LLC $3.84M

BANK OF AMERICA CORP /DE/ $3.48M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
HBM Healthcare Investments (Cayman) Ltd.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$2,784,714 2,690,545 shares	—	09 Nov 2021
Novo Holdings A/S	13F Company 13F	— denominator unverified	$6,146,123 3,277,932 shares	—	31 Mar 2023
Vivo Capital, LLC	13F Company 13F	— denominator unverified	$5,654,147 3,015,545 shares	—	31 Mar 2023
Avoro Capital Advisors LLC	13F Company 13F	— denominator unverified	$3,844,501 2,055,883 shares	—	31 Mar 2023
BANK OF AMERICA CORP /DE/	13F Company 13F	— denominator unverified	$3,476,597 1,854,185 shares	—	31 Mar 2023
Point72 Asset Management, L.P.	13F Company 13F	— denominator unverified	$2,625,000 1,400,000 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

12,246,779

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2023 holders

Holder diff

Investor	Q1 2026 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend